Safety and extrapulmonary effects of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis following lung transplantation: A systematic review and meta-analysis.

Venditto L, Neece A, Forgione F, Testa I, Da Pian M, Aurora P, Liou TG, Terlizzi V.

Open source

DOI
10.1016/j.prrv.2026.04.002
Published
2026-04-21
Container
Paediatr Respir Rev
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.prrv.2026.04.002,
  title = {Safety and extrapulmonary effects of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis following lung transplantation: A systematic review and meta-analysis.},
  author = {Venditto L and  Neece A and  Forgione F and  Testa I and  Da Pian M and  Aurora P and  Liou TG and  Terlizzi V.},
  year = {2026},
  journal = {Paediatr Respir Rev},
  doi = {10.1016/j.prrv.2026.04.002},
  url = {https://doi.org/10.1016/j.prrv.2026.04.002}
}

RIS

TY  - JOUR
TI  - Safety and extrapulmonary effects of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis following lung transplantation: A systematic review and meta-analysis.
AU  - Venditto L
AU  -  Neece A
AU  -  Forgione F
AU  -  Testa I
AU  -  Da Pian M
AU  -  Aurora P
AU  -  Liou TG
AU  -  Terlizzi V.
PY  - 2026
JO  - Paediatr Respir Rev
DO  - 10.1016/j.prrv.2026.04.002
UR  - https://doi.org/10.1016/j.prrv.2026.04.002
ER  - 

APA

L, V., A, N., F, F., I, T., M, D. P., P, A., TG, L., & V., T. (2026). Safety and extrapulmonary effects of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis following lung transplantation: A systematic review and meta-analysis.. Paediatr Respir Rev. https://doi.org/10.1016/j.prrv.2026.04.002

Source records